A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Clinical trial NCT05861947 · TERMINATED

Trial details

NCT number: NCT05861947
Sponsor: Aurigene Discovery Technologies Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapse Advanced Malignant Neoplasm Non Small Cell Lung Cancer Gastric Cancer Urothelial Carcinoma Kidney Cancer Colon Cancer Esophagus Cancer

Start date: 2023-08-26
Primary completion: 2026-02-10
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.